These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10691996

  • 1. Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes.
    Benz C, Angermüller S, Otto G, Sauer P, Stremmel W, Stiehl A.
    Eur J Clin Invest; 2000 Mar; 30(3):203-9. PubMed ID: 10691996
    [Abstract] [Full Text] [Related]

  • 2. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes.
    Benz C, Angermüller S, Töx U, Klöters-Plachky P, Riedel HD, Sauer P, Stremmel W, Stiehl A.
    J Hepatol; 1998 Jan; 28(1):99-106. PubMed ID: 9537871
    [Abstract] [Full Text] [Related]

  • 3. Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes.
    Benz C, Angermüller S, Klöters-Plachky P, Sauer P, Stremmel W, Stiehl A.
    Eur J Clin Invest; 1998 Jul; 28(7):577-83. PubMed ID: 9726039
    [Abstract] [Full Text] [Related]

  • 4. Effect of bile acids on the proliferative activity and apoptosis of rat hepatocytes.
    Danchenko E, Petermann H, Chirkin A, Dargel R.
    Exp Toxicol Pathol; 2001 Jun; 53(2-3):227-33. PubMed ID: 11484843
    [Abstract] [Full Text] [Related]

  • 5. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.
    Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, Haisma HJ, Jansen PL, Moshage H.
    Hepatology; 2004 Jun; 39(6):1563-73. PubMed ID: 15185297
    [Abstract] [Full Text] [Related]

  • 6. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation.
    Schoemaker MH, Gommans WM, Conde de la Rosa L, Homan M, Klok P, Trautwein C, van Goor H, Poelstra K, Haisma HJ, Jansen PL, Moshage H.
    J Hepatol; 2003 Aug; 39(2):153-61. PubMed ID: 12873810
    [Abstract] [Full Text] [Related]

  • 7. Bile Acid Toxicity and Protein Kinases.
    Engin A.
    Adv Exp Med Biol; 2021 Aug; 1275():229-258. PubMed ID: 33539018
    [Abstract] [Full Text] [Related]

  • 8. Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
    Verhaag EM, Buist-Homan M, Koehorst M, Groen AK, Moshage H, Faber KN.
    PLoS One; 2016 Aug; 11(3):e0149782. PubMed ID: 26950211
    [Abstract] [Full Text] [Related]

  • 9. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes.
    Azzaroli F, Mehal W, Soroka CJ, Wang L, Lee J, Crispe IN, Boyer JL.
    Hepatology; 2002 Jul; 36(1):49-54. PubMed ID: 12085348
    [Abstract] [Full Text] [Related]

  • 10. Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis.
    Paridaens A, Raevens S, Devisscher L, Bogaerts E, Verhelst X, Hoorens A, Van Vlierberghe H, van Grunsven LA, Geerts A, Colle I.
    Int J Mol Sci; 2017 Jan 20; 18(1):. PubMed ID: 28117681
    [Abstract] [Full Text] [Related]

  • 11. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S, Ballet F, Franco D, Setchell KD, Poupon R.
    Hepatology; 1995 Jul 20; 22(1):82-7. PubMed ID: 7601437
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis and modulation of cell cycle control by bile acids in human leukemia T cells.
    Fimognari C, Lenzi M, Cantelli-Forti G, Hrelia P.
    Ann N Y Acad Sci; 2009 Aug 20; 1171():264-9. PubMed ID: 19723064
    [Abstract] [Full Text] [Related]

  • 13. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis.
    Karimian G, Buist-Homan M, Schmidt M, Tietge UJ, de Boer JF, Klappe K, Kok JW, Combettes L, Tordjmann T, Faber KN, Moshage H.
    Biochim Biophys Acta; 2013 Dec 20; 1832(12):1922-9. PubMed ID: 23816565
    [Abstract] [Full Text] [Related]

  • 14. Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis.
    Beuers U, Nathanson MH, Isales CM, Boyer JL.
    J Clin Invest; 1993 Dec 20; 92(6):2984-93. PubMed ID: 8254052
    [Abstract] [Full Text] [Related]

  • 15. Tauro-β-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential.
    Denk GU, Kleiss CP, Wimmer R, Vennegeerts T, Reiter FP, Schulz S, Zischka H, Rust C.
    Biochem Biophys Res Commun; 2012 Aug 10; 424(4):758-64. PubMed ID: 22809502
    [Abstract] [Full Text] [Related]

  • 16. Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytes.
    Hirano F, Haneda M, Makino I.
    J Gastroenterol Hepatol; 2006 Dec 10; 21(12):1807-13. PubMed ID: 17074018
    [Abstract] [Full Text] [Related]

  • 17. Tauroursodeoxycholate Protects Rat Hepatocytes from Bile Acid-Induced Apoptosis via β1-Integrin- and Protein Kinase A-Dependent Mechanisms.
    Sommerfeld A, Reinehr R, Häussinger D.
    Cell Physiol Biochem; 2015 Dec 10; 36(3):866-83. PubMed ID: 26044599
    [Abstract] [Full Text] [Related]

  • 18. Phosphatidylinositol-3-kinase p110γ contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells.
    Hohenester S, Gates A, Wimmer R, Beuers U, Anwer MS, Rust C, Webster CR.
    J Hepatol; 2010 Nov 10; 53(5):918-26. PubMed ID: 20675006
    [Abstract] [Full Text] [Related]

  • 19. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.
    Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH, Gores GJ.
    J Clin Invest; 1999 Jan 10; 103(1):137-45. PubMed ID: 9884343
    [Abstract] [Full Text] [Related]

  • 20. Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure.
    Vandewynckel YP, Laukens D, Devisscher L, Paridaens A, Bogaerts E, Verhelst X, Van den Bussche A, Raevens S, Van Steenkiste C, Van Troys M, Ampe C, Descamps B, Vanhove C, Govaere O, Geerts A, Van Vlierberghe H.
    Oncotarget; 2015 Sep 29; 6(29):28011-25. PubMed ID: 26293671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.